Methyl Methanesulfonate clinical trials
How each study uses Methyl Methanesulfonate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Methyl Methanesulfonate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Other names
- MMS
- 1
Studies by the year they started
6 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2022 | 1 |
| 2025 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 6
ETH Zurich (1) · Indonesia Timur University (1) · Harvard School of Public Health (HSPH) (1) · Institute of Tropical Medicine, Belgium (1) · Sindh Institute of Child Health and Neonatology (1) · Johns Hopkins Bloomberg School of Public Health (1)
Often tested with
Tested in the same studies.
Iron (3) · Incomplete Freund's adjuvant (2) · Folic Acid (2) · Chloroquine (1) · Fanasil, pyrimethamine drug combination (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test Methyl Methanesulfonate.
- Nov 2026Iron Absorption From IFA and MMS Supplements in Kenyan Women During the Second Trimester of PregnancyNot applicable · ETH Zurich
- Dec 2026MMS, IFA, and MMS+IFA Supplementation in Pregnant WomenNot applicable · Sindh Institute of Child Health and Neonatology
- Dec 2026Implementation of Multiple Micronutrient Supplementation (MMS) for Pregnant Women in UgandaNot applicable · Johns Hopkins Bloomberg School of Public Health
Studies
Open first, then newest update. How each study uses Methyl Methanesulfonate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Implementation of Multiple Micronutrient Supplementation (MMS) for Pregnant Women in UgandaRecruitingNot applicableJohns Hopkins Bloomberg School of Public HealthNCT06835738Written as Multiple Micronutrient Supplement (MMS) - dispensed in six 30-count bottles
- MMS, IFA, and MMS+IFA Supplementation in Pregnant WomenNot yet recruitingNot applicableSindh Institute of Child Health and NeonatologyNCT07665957Written as Multiple Micronutrient Supplementation (MMS)
- Iron Absorption From IFA and MMS Supplements in Kenyan Women During the Second Trimester of PregnancyActive, not recruitingNot applicableETH ZurichNCT07435766Written as MMS with 30 mg iron
- Multiple Micronutrient Versus Iron-Folic Acid Supplementation in Pregnant Women in IndonesiaCompletedNot applicableIndonesia Timur UniversityNCT07725549Written as Multiple micronutrient supplementation
- School-Based Assessment of Micronutrient Interventions in Adolescents (SAMIA) in ZanzibarCompletedNot applicableHarvard School of Public Health (HSPH)NCT05104554Written as Multiple Micronutrient Supplement (MMS)
- Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria ComponentCompletedPhase 4Institute of Tropical Medicine, BelgiumNCT00680732Written as Multiple micronutrients supplements (MMS)
Given beside what is tested · 1 — Methyl Methanesulfonate is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Methyl Methanesulfonate
- The MOM-CARE Trial : Evaluating Antenatal and Postnatal MMSPlus for Improved Infant Birth and Growth OutcomesRecruitingPhase 3Aga Khan UniversityNCT07029282Written as MMS
- BEP Supplementation Research in Bangladesh (JiVitA-BEP-IR)CompletedNot applicableJohns Hopkins Bloomberg School of Public HealthNCT05576207Written as Multiple Micronutrient Supplement for pregnant women
Codes
What other systems call Methyl Methanesulfonate · ClinicalTrials.gg INT007813
- MeSH (NLM) D008741Methyl MethanesulfonateConfirmed NLM, Wikidata
- UNII (FDA) AT5C31J09GMETHYL METHANESULFONATEConfirmed FDA, NLM, Wikidata
- Wikidata Q3077242methyl methanesulfonateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C44399Methyl MethanesulfonateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D008741 | Methyl Methanesulfonate | Confirmed NLM, Wikidata |
| UNII (FDA) | AT5C31J09G | METHYL METHANESULFONATE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q3077242 | methyl methanesulfonate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C44399 | Methyl Methanesulfonate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.